Abstract
There is mounting evidence of a link between the properties of electroencephalograms (EEGs) of depressive patients and the outcome of pharmacotherapy. The goal of this study was to develop an EEG biomarker of antidepressant treatment response which would require only a single EEG measurement. We recorded resting 21-channel EEG in 17 in-patients suffering from bipolar depression in eyes-closed and eyes-open conditions. The EEG measurement was performed at the end of a short washout period which followed previous unsuccessful pharmacotherapy. We calculated the normalized wavelet power of alpha rhythm using two referential montages and an average reference montage. The difference in the normalized alpha wavelet power between 10 responders and 7 non-responders was most strongly pronounced in link mastoid montage in the eyes-closed condition. In particular, in the occipital (O1, O2, Oz) channels the wavelet power of responders was up to 84 % higher than that of non-responders. Using a novel classification algorithm we were able to correctly predict the outcome of treatment with 90 % sensitivity and 100 % specificity. The proposed biomarker requires only a single EEG measurement and consequently is intrinsically different from biomarkers which exploit the changes in prefrontal EEG induced by pharmacotherapy over a given time.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bares M, Brunovsky M, Kopecek M, Stopkova P, Novak T, Kozeny J, Höschl C (2007) Changes in QEEG prefrontal cordance as a predictor of response to antidepressants in patients with treatment resistant depressive disorder: a pilot study. J Psychiatr Res 41:319–325
Bares M, Brunovsky M, Kopecek M, Novak T, Stopkova P, Kozeny J, Sos P, Krajca V, Höschl C (2008) Early reduction in prefrontal theta QEEG cordance value predicts response to venlafaxine treatment in patients with resistant depressive disorder. Eur Psychiatry 23:350–355
Bares M, Brunovsky M, Novak T, Kopecek M, Stopkova P, Sos P, Krajca V, Höschl C (2010) The change of prefrontal QEEG theta cordance as a predictor of response to bupropion treatment in patients who had failed to respond to previous antidepressant treatments. Eur Neuropsychopharmacol 20:459–466
Bares M, Novak T, Brunovsky M, Kopecek M, Stopkova P, Krajca V, Höschl C (2012) The change of QEEG prefrontal cordance as a response predictor to antidepressive intervention in bipolar depression. A pilot study. J Psychiatr Res 46:219–225
Baskaran A, Milev R, McIntyre RS (2012) The neurobiology of the EEG biomarker as a predictor of treatment response in depression. Neuropharmacology 63:507–513
Bauer M, Bschor T, Pfennig A, Whybrow PC, Angst J, Versiani M, Möller H-J (2007) World Federation of Societies of Biological Psychiatry (WFSBP). Guidelines for biological treatment of unipolar depressive disorders in primary care. World J Biol Psychiatry 8:67–104
Bruder GE, Stewart JW, Tenke CE, McGrath PJ, Leite P, Bhattacharya N, Quitkin FM (2001) Electroencephalographic and perceptual asymmetry differences between responders and non-responders to an SSRI antidepressant. Biol Psychiatry 49:416–425
Bruder GE, Tenke CE, Warner V, Nomura Y, Grillon C, Hille J, Leite P, Weissman MM (2005) Electroencephalographic measures of regional hemispheric activity in offspring at risk for depressive disorders. Biol Psychiatry 57:328–335
Bruder GE, Sedoruk JP, Stewart JW, McGrath PJ, Quitkin FM, Tenke CE (2008) Electroencephalographic alpha measures predict therapeutic response to a selective serotonin reuptake inhibitor antidepressant: pre- and post-treatment findings. Biol Psychiatry 63:1171–1177
Cipriani A, Furukawa TA, Salanti G, Geddes JR, Higgins JPT, Churchill R, Watanabe N, Nakagawa A (2009) Comparative effi cacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet 373:746–758
Cook IA, Leuchter AF, Witte E, Abrams M, Uijtdehaage SH, Stubbeman W, Rosenberg-Thompson S, Anderson-Hanley C, Dunkin JJ (1999) Neurophysiologic predictors of treatment response to fluoxetine in major depression. Psychiatry Res 85:263–273
Cook IA, Leuchter AF, Morgan M, Witte E, Stubbeman WF, Abrams M, Rosenberg S, Uijtdehaage SHJ (2002) Early changes in prefrontal activity characterize clinical responders to antidepressants. Neuropsychopharmacology 27:120–131
Cook IA, Leuchter AF, Morgan ML, Stubbeman W, Siegman B, Abrams M (2005) Changes in prefrontal activity characterize clinical response in SSRI non-responders: a pilot study. J Psychiatr Res 39:461–466
Cook IA, Hunter AM, Abrams M, Siegman B, Leuchter AF (2009) Midline and right frontal brain function as a physiologic biomarker of remission in major depression. Psychiatry Res 174:152–157
Cover T, Hart P (1967) Nearest neighbor pattern classification. IEEE Trans Inf Theory 13:21–27
Debener S, Beauducel A, Nessler D, Brocke B, Heilemann H, Kayser J (2000) Is resting anterior EEG alpha asymmetry a trait marker for depression? Neuropsychobiology 41:31–37
Dunner DL (2003) Clinical consequences of under-recognized bipolar spectrum disorder. Bipolar Disord 5:456–463
Frye MA, Prieto ML, Bobo WV, Kung S, Veldic M, Alarcon RD, Moore KM, Choi D-S, Biernacka JM, Tye SJ (2014) Current landscape, unmet needs, and future directions for treatment of bipolar depression. J Affect Disord 169S1:S17–S23
Goodwin FK, Jamison KR (2007) Manic-depressive illness: bipolar disorders and recurrent depression, 2nd edn. Oxford University Press, Oxford
Hanley JA (1989) Receiver operating characteristic (ROC) methodology: the state of the art. Crit Rev Diagn Imaging 29:307–335
Iosifescu DV (2011) Electroencephalography-derived biomarkers of antidepressant response. Harv Rev Psychiatry 19:144–154
Iosifescu DV, Greenwald S, Devlin P, Mischoulon D, Denninger JW, Alpert JE, Fava M (2009) Frontal EEG predictors of treatment outcome in major depressive disorder. Eur Neuropsychopharmacol 19:772–777
Klimesch W (1997) EEG-alpha rhythms and memory processes. Int J Psychophysiol 26:319–340
Klimesch W (1999) EEG alpha and theta oscillations reflect cognitive and memory performance: a review and analysis. Brain Res Brain Res Rev 29:169–195
Knott VJ, Telner JI, Lapierre YD, Browne M, Horn ER (1996) Quantitative EEG in the prediction of antidepressant response to imipramine. J Affect Disord 39:175–184
Knott V, Mahoney C, Kennedy S, Evans K (2000) Pre-treatment EEG and it’s relationship to depression severity and paroxetine treatment outcome. Pharmacopsychiatry 33:201–205
Latka M, Was Z, Kozik A, West BJ (2003) Wavelet analysis of epileptic spikes. Phys Rev E Stat Nonlinear Soft Matter Phys 67:52902
Latka M, Turalska M, Glaubic-Latka M, Kolodziej W, Latka D, West BJ (2005) Phase dynamics in cerebral autoregulation. Am J Physiol Heart Circ Physiol 289:H2272–H2279
Lee P-S, Chen Y-S, Hsieh J-C, Su T-P, Chen L-F (2010) Distinct neuronal oscillatory responses between patients with bipolar and unipolar disorders: a magnetoencephalographic study. J Affect Disord 123:270–275
Leuchter AF, Cook IA, Hunter A, Korb A (2009a) Use of clinical neurophysiology for the selection of medication in the treatment of major depressive disorder: the state of the evidence. Clin EEG Neurosci 40:78–83
Leuchter AF, Cook IA, Gilmer WS, Marangell LB, Burgoyne KS, Howland RH, Trivedi MH, Zisook S, Jain R, Fava M, Iosifescu D, Greenwald S (2009b) Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder. Psychiatry Res 169:132–138
Leuchter AF, Cook IA, Marangell LB, Gilmer WS, Burgoyne KS, Howland RH, Trivedi MH, Zisook S, Jain R, McCracken JT, Fava M, Iosifescu D, Greenwald S (2009c) Comparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in major depressive disorder: results of the BRITE-MD study. Psychiatry Res 169:124–131
Lieber AL (1988) Diagnosis and subtyping of depressive disorders by quantitative electroencephalography: II. Interhemispheric measures are abnormal in major depressives and frequency analysis may discriminate certain subtypes. Hillside J Clin Psychiatry 10:84–97
Niedermeyer E (2005) The normal EEG of the waking adult. In: Niedermeyer E, Da Silva F L (eds) Electroencephalography: basic principles, clinical applications, and related fields, 5th edn. Lippincott Williams & Wilkins, Philadelphia, pp 167–192
Rush AJ, Trivedi MH, Wisniewski SR, Stewart JW, Nierenberg AA, Thase ME, Ritz L, Biggs MM, Warden D, Luther JF, Shores-Wilson K, Niederehe G, Fava M (2006) Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. N Engl J Med 354:1231–1242
Shaw JC (2003) The brain’s alpha rhythms and the mind. Elsevier, Amsterdam
Small JG (2005) Psychiatric disorders and EEG. In: Niedermeyer E, Da Silva F L (eds) Electroencephalography: basic principles, clinical applications, and related fields, 5th edn. Lippincott Williams & Wilkins, Philadelphia, pp 639–659
Stahl SM, Grady MM (2003) Differences in mechanism of action between current and future antidepressants. J Clin Psychiatry 64(Suppl 1):13–17
Tas C, Cebi M, Tan O, Hızlı-Sayar G, Tarhan N, Brown EC (2014) EEG power, cordance and coherence differences between unipolar and bipolar depression. J Affect Disord 172C:184–190
Tenke CE, Kayser J, Manna CG, Fekri S, Kroppmann CJ, Schaller JD, Alschuler DM, Stewart JW, McGrath PJ, Bruder GE (2011) Current source density measures of electroencephalographic alpha predict antidepressant treatment response. Biol Psychiatry 70:388–394
Thase ME, Rush AJ (1997) When at first you don’t succeed: sequential strategies for antidepressant non-responders. J Clin Psychiatry 58(Suppl 1):23–29
Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, Norquist G, Howland RH, Lebowitz B, McGrath PJ, Shores-Wilson K, Biggs MM, Balasubramani GK, Fava M (2006) Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry 163:28–40
Tundo A, Calabrese JR, Proietti L, de Filippis R (2014) Short-term antidepressant treatment of bipolar depression: are ISBD recommendations useful in clinical practice? J Affect Disord 171C:155–160
Ulrich G, Renfordt E, Zeller G, Frick K (1984) Interrelation between changes in the EEG and psychopathology under pharmacotherapy for endogenous depression. A contribution to the predictor question. Pharmacopsychiatry 17:178–183
Ulrich G, Renfordt E, Frick K (1986) The topographical distribution of alpha-activity in the resting EEG of endogenous-depressive in-patients with and without clinical response to pharmacotherapy. Pharmacopsychiatry 19:272–273
Vázquez GH, Tondo L, Undurraga J, Baldessarini RJ (2013) Overview of antidepressant treatment of bipolar depression. Int J Neuropsychopharmacol 16:1673–1685
Acknowledgments
This research was supported by an Intramural Grant from the Institute of Psychiatry and Neurology in Warsaw.
Conflicts of Interests
The authors declare no conflicts of interest in relation to this article.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Jernajczyk, W., Gosek, P., Latka, M., Kozlowska, K., Święcicki, Ł., West, B.J. (2017). Alpha Wavelet Power as a Biomarker of Antidepressant Treatment Response in Bipolar Depression. In: Pokorski, M. (eds) Influenza and Respiratory Care. Advances in Experimental Medicine and Biology(), vol 968. Springer, Cham. https://doi.org/10.1007/5584_2016_180
Download citation
DOI: https://doi.org/10.1007/5584_2016_180
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-51711-7
Online ISBN: 978-3-319-51712-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)